169 related articles for article (PubMed ID: 25400738)
1. CREPT expression correlates with poor prognosis in patients with retroperitoneal leiomyosarcoma.
She Y; Liang J; Chen L; Qiu Y; Liu N; Zhao X; Huang X; Wang Y; Ren F; Chang Z; Li P
Int J Clin Exp Pathol; 2014; 7(10):6596-605. PubMed ID: 25400738
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors analysis of Ki-67, α-SMA expression in retroperitoneal leiomyosarcoma].
Ma C; Li PY; Zhang N; Sun CB; Hou L; Liu N
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):258-263. PubMed ID: 29730911
[No Abstract] [Full Text] [Related]
3. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas.
Paal E; Miettinen M
Am J Surg Pathol; 2001 Nov; 25(11):1355-63. PubMed ID: 11684951
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.
Li Q; Zhuang R; Zhu J; Lu W; Hou Y; Liu J; Zhang Y; Wang Y; Liu T; Wang Z; Zhou Y
Future Oncol; 2015; 11(12):1759-66. PubMed ID: 26075444
[TBL] [Abstract][Full Text] [Related]
5. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
6. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CD133 in primary retroperitoneal leiomyosarcoma and its relationship with Ki-67].
She Y; Liang J; Qiu Y; Liu N; Huang X; Zhao X; Li P
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1241-4. PubMed ID: 24924889
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
[TBL] [Abstract][Full Text] [Related]
9. Primary and secondary leiomyosarcoma of the oral and perioral region--clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature.
Schütz A; Smeets R; Driemel O; Hakim SG; Kosmehl H; Hanken H; Kolk A
J Oral Maxillofac Surg; 2013 Jun; 71(6):1132-42. PubMed ID: 23434173
[TBL] [Abstract][Full Text] [Related]
10. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
[TBL] [Abstract][Full Text] [Related]
11. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
[TBL] [Abstract][Full Text] [Related]
12. Leiomyosarcoma in soft tissue: examination of p53 status and cell proliferating factors in different locations.
Konomoto T; Fukuda T; Hayashi K; Kumazawa J; Tsuneyoshi M
Hum Pathol; 1998 Jan; 29(1):74-81. PubMed ID: 9445137
[TBL] [Abstract][Full Text] [Related]
13. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.
Gronchi A; Collini P; Miceli R; Valeri B; Renne SL; Dagrada G; Fiore M; Sanfilippo R; Barisella M; Colombo C; Morosi C; Stacchiotti S; Casali PG; Dei Tos AP; Pilotti S
Am J Surg Pathol; 2015 Mar; 39(3):383-93. PubMed ID: 25581729
[TBL] [Abstract][Full Text] [Related]
14. Predictors of survival and recurrence in primary leiomyosarcoma.
Gladdy RA; Qin LX; Moraco N; Agaram NP; Brennan MF; Singer S
Ann Surg Oncol; 2013 Jun; 20(6):1851-7. PubMed ID: 23354568
[TBL] [Abstract][Full Text] [Related]
15. High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer.
Zheng G; Li W; Zuo B; Guo Z; Xi W; Wei M; Chen P; Wen W; Yang AG
Biochem Biophys Res Commun; 2016 Nov; 480(3):436-442. PubMed ID: 27773816
[TBL] [Abstract][Full Text] [Related]
16. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.
Tian W; Wang G; Yang J; Pan Y; Ma Y
Med Oncol; 2013 Mar; 30(1):401. PubMed ID: 23292832
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract: a clinicopathologic analysis of 17 cases.
Rajani B; Smith TA; Reith JD; Goldblum JR
Mod Pathol; 1999 Jan; 12(1):21-8. PubMed ID: 9950158
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in retroperitoneal sarcomas: ploidy of DNA as a predictor of clinical outcome.
Herman K; Gruchała A; Niezabitowski A; Gliński B; Lackowska B
J Surg Oncol; 1999 May; 71(1):32-5. PubMed ID: 10362089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
